DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, providing promising enhancements across a variety of health care and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, a lot more trustworthy alternate for therapeutic use